|
Volumn 16, Issue 1, 2001, Pages 7-17
|
Cell-based screening approach for antitumor drug leads which exploits sensitivity differences between normal and cancer cells: Identification of two novel cell-cycle inhibitors
a
|
Author keywords
Antitumor; Cancer cells; Cell cycle; High throughput; Mitosis
|
Indexed keywords
2 BROMO 1 ETHOXYBENZENE;
3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE;
5 ETHOXY 2 NITROBENZALDEHYDE;
ANTIMITOTIC AGENT;
ANTINEOPLASTIC AGENT;
BROMINE DERIVATIVE;
RO 236538;
RO 911311;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER CELL;
CELL CULTURE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SCREENING;
DRUG SPECIFICITY;
DRUG STRUCTURE;
FEMALE;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MITOSIS INHIBITION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BREAST NEOPLASMS;
CELL CYCLE;
DRUG SCREENING ASSAYS, ANTITUMOR;
FEMALE;
HUMANS;
INDICATORS AND REAGENTS;
MAGNETIC RESONANCE SPECTROSCOPY;
METAPHASE;
NEOPLASMS;
PHOSPHORYLATION;
PROTO-ONCOGENE PROTEINS C-BCL-2;
TUBULIN;
TUMOR CELLS, CULTURED;
ANIMALIA;
|
EID: 0035203298
PISSN: 02669536
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (23)
|
References (22)
|